サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786727

ヒヨスチンの世界市場

Hyoscine

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
ヒヨスチンの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヒヨスチンの世界市場は2030年までに5億440万米ドルに達する見込み

2024年に4億2,430万米ドルと推定されるヒヨスチンの世界市場は、2030年には5億440万米ドルに達し、分析期間2024-2030年のCAGRは2.9%で成長すると予測されます。ヒヨスチン臭化ブチルタイプは、本レポートで分析しているセグメントの1つであり、CAGR 2.3%を記録し、分析期間終了時には3億4,160万米ドルに達すると予測されています。ヒヨスチン臭化水素酸塩タイプの成長率は、分析期間中CAGR 4.3%と推定されます。

米国市場は1億1,560万米ドルと推定、中国はCAGR 5.4％で成長予測

米国のヒヨスチン市場は、2024年に1億1,560万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに9,780万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.2%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界のヒヨスチン市場- 主要動向と促進要因のまとめ

ヒヨスチンが現代の治療現場で注目される理由とは？

スコポラミンとしても知られるヒヨスチンは、制吐作用、鎮痙作用、乗り物酔い緩和作用のために主に使用される、定評ある抗コリン薬です。中枢神経系と消化管にあるムスカリン受容体を遮断するユニークな能力により、吐き気、嘔吐、胃腸けいれん、過敏性腸症候群（IBS）、パーキンソン病関連のよだれなど、幅広い症状の管理に有効です。平滑筋関連障害や動作に関連した吐き気に対する効果的な非オピオイド治療に対する需要が高まっているため、ヒヨスチンは長年にわたって臨床的な関連性を取り戻しています。手術や緩和ケアの場面では、分泌物や不快感の管理に頻繁に使用され、患者のQOLを高めています。さらに、小児および成人の集団における旅行関連の乗り物酔いに対する意識の高まりが、経皮吸収パッチや経口製剤の需要を促進しています。世界のヘルスケアシステムが、より個別化され、症状をターゲットにした治療薬へとシフトする中、ヒヨスチンは、その多様な用途と迅速な作用発現により、医師や医薬品開発者の間で再び関心を集めています。

製剤技術革新は、ヒヨスチンの市場用途をどのように拡大していますか？

製薬技術革新はヒヨスチン市場を再形成しており、代替デリバリーシステムと患者アドヒアランスの向上に重点を置いています。従来の経口剤や注射剤は現在、経皮パッチ、舌下錠、点鼻薬、頬部フィルムによって補完され、より制御された薬物放出とより長い作用時間を実現しています。特に経皮吸収型パッチは、数日間にわたり治療レベルを持続させることで乗り物酔いの予防に革命をもたらし、長距離旅行やクルーズ船の乗客に理想的な薬となっています。ナノ粒子を用いたデリバリーや標的消化管放出システムに関する最近の調査でも、バイオアベイラビリティが改善され、ヒヨスチンの全身的副作用が最小限に抑えられています。これらの開発により、薬剤の忍容性が向上し、小児用や老人用の製剤への道が開かれつつあります。さらに、ヒヨスチンと他の吐き気止めや鎮痙剤との併用療法が、複雑な胃腸疾患や神経疾患の治療のために研究されています。このような先進的な製剤が主流のヘルスケアに統合されることで、ヒヨスチンの市場ポテンシャルは、様々な患者層や臨床ニーズにおいて大きく拡大しています。

市場力学に影響を与える規制・臨床開発とは？

規制当局の承認、特許活動、臨床研究イニシアチブは、世界の市場情勢の競争状況を形成しています。米国FDA、EMA、新興市場の国家機関などの規制機関は、新しいヒヨスチンベースの治療薬、特に乗り物酔い、術後の回復、緩和ケア用にデザインされた経皮・経鼻剤を承認し続けています。ヒヨスチンは強力な安全性プロファイルを持ち、数十年にわたる臨床使用実績があるため、新規の薬物とデバイスの組み合わせに含まれる場合、しばしば迅速な規制経路を享受することができます。同時に、アルツハイマー病、パーキンソン病関連のよだれ、麻酔後せん妄を含む神経疾患への使用に関する臨床調査の増加は、新たな治療カテゴリーへの拡大を示唆しています。世界のファーマコビジランスデータは、ヒヨスチンの有効性と安全性を継続的に裏付けており、臨床医の間での評価を高めています。これと並行して、市場各社はデリバリー技術の向上や適応症の拡大に投資することで、規制上の独占権やライフサイクルマネジメント戦略を追求しています。臨床試験と製品イノベーションのパイプラインの増加は、混雑した鎮痙・制吐剤市場においてメーカーが製品を差別化するのに役立っています。

ヒヨスチン市場の成長促進要因は？

ヒヨスチン市場の成長は、薬剤の再製剤化、エンドユーザーの需要、治療の汎用性、世界の健康動向などに関するいくつかの要因によってもたらされます。第一に、先進国、新興諸国ともに乗り物酔いや胃腸障害の発生率が上昇しており、即効性があり、忍容性の高い対症療法に対する需要が高まっています。第二に、特に北米、欧州、日本における高齢化人口の増加により、緩和ケア、パーキンソン病管理、術後の症状緩和など、ヒヨスチンに基づく製品に対する需要が高まっています。第三に、消費者健康市場における市販のヒヨスチン製品の利用可能性の増加により、特に旅行関連の用途において、処方箋のみの設定からその範囲を広げています。第四に、パッチ、点鼻薬、徐放錠剤などのドラッグデリバリーシステムの進歩が、患者のコンプライアンスと治療効果を向上させ、ヒヨスチンを様々な層にアピールしています。第五に、製薬企業は地域市場の拡大に積極的に投資しており、特にアジア太平洋やラテンアメリカでは、消化器系や中枢神経系の治療薬に対する需要が急速に高まっています。最後に、強力な臨床エビデンス、進行中の調査、規制状況のサポートにより、世界の製薬業界において、信頼され、適応性が高く、ますます革新的な治療オプションとしての情勢の確立が進んでいます。

セグメント

タイプ（ヒヨスチン臭化ブチルタイプ、ヒヨスチン臭化水素酸塩タイプ）、投与（経口投与、貼付投与、注射投与）

調査対象企業の例

  • Actylis
  • AdvaCare Pharma
  • Alchem International Pvt. Ltd
  • Aspen API
  • Atman Pharmaceuticals
  • Baxter International Inc.
  • Bazayan & Co
  • Biotechnica DWC
  • Caleb Pharmaceuticals Inc.
  • GlaxoSmithKline plc（GSK）
  • Jai Radhe Sales
  • LGM Pharma
  • Linnea SA
  • MYUNGMOON PHARM CO., LTD.
  • Perrigo Company plc
  • Phytex Australia
  • Rumit Group of Companies
  • Sarv Biolabs Pvt. Ltd
  • Transo-Pharm Handels GmbH
  • Zhejiang Ausun Pharmaceutical Co., Ltd.

AIインテグレーション

当社は、検証済みの専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31515

Global Hyoscine Market to Reach US$504.4 Million by 2030

The global market for Hyoscine estimated at US$424.3 Million in the year 2024, is expected to reach US$504.4 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Hyoscine Butyl Bromide Type, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$341.6 Million by the end of the analysis period. Growth in the Hyoscine Hydrobromide Type segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$115.6 Million While China is Forecast to Grow at 5.4% CAGR

The Hyoscine market in the U.S. is estimated at US$115.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$97.8 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Hyoscine Market - Key Trends & Drivers Summarized

Why Is Hyoscine Regaining Focus in Modern Therapeutic Practices?

Hyoscine, also known as scopolamine, is a well-established anticholinergic drug used primarily for its antiemetic, antispasmodic, and motion sickness-relieving properties. Its unique ability to block muscarinic receptors in the central nervous system and gastrointestinal tract makes it effective in managing a wide range of conditions, including nausea, vomiting, gastrointestinal cramps, irritable bowel syndrome (IBS), and Parkinson’s-related drooling. Over the years, hyoscine has regained clinical relevance due to the growing demand for effective non-opioid treatments for smooth muscle-related disorders and motion-related nausea. In surgical and palliative care settings, it is frequently used to manage secretions and discomfort, enhancing patient quality of life. Moreover, the rising awareness of travel-related motion sickness in both pediatric and adult populations has fueled demand for transdermal hyoscine patches and oral formulations. As global healthcare systems shift towards more personalized and symptom-targeted therapeutics, hyoscine is seeing renewed interest among physicians and pharmaceutical developers for its diverse applications and rapid onset of action.

How Are Formulation Innovations Expanding Hyoscine's Market Applications?

Pharmaceutical innovations are reshaping the hyoscine market, with a strong emphasis on alternative delivery systems and improved patient adherence. Traditional oral and injectable forms are now complemented by transdermal patches, sublingual tablets, nasal sprays, and buccal films, which offer more controlled drug release and longer durations of action. The transdermal patch, in particular, has revolutionized the prevention of motion sickness by providing sustained therapeutic levels over several days, making it ideal for long-distance travel or cruise ship passengers. Recent research into nanoparticle-based delivery and targeted gastrointestinal release systems is also improving the bioavailability and minimizing systemic side effects of hyoscine. These developments are enhancing the drug’s tolerability and opening avenues for pediatric-friendly and geriatric-use formulations. Additionally, combination therapies that include hyoscine with other antinausea or antispasmodic agents are being investigated to treat complex gastrointestinal and neurological conditions. The integration of these advanced formulations into mainstream healthcare practice is significantly expanding hyoscine’s market potential across different patient demographics and clinical needs.

What Regulatory and Clinical Developments Are Influencing Market Dynamics?

Regulatory approvals, patent activity, and clinical research initiatives are shaping the competitive landscape of the global hyoscine market. Regulatory bodies such as the U.S. FDA, EMA, and national agencies in emerging markets continue to approve new hyoscine-based therapies, particularly transdermal and intranasal forms designed for motion sickness, postoperative recovery, and palliative care. With a strong safety profile and decades of clinical usage, hyoscine often enjoys expedited regulatory pathways when included in novel drug-device combinations. At the same time, increased clinical investigation into its use for neurological conditions-including Alzheimer's, Parkinson's-related drooling, and post-anesthesia delirium-signals an expansion into new therapeutic categories. Global pharmacovigilance data continues to support the efficacy and safety of hyoscine, strengthening its reputation among clinicians. In parallel, market players are pursuing regulatory exclusivity and lifecycle management strategies by investing in improved delivery technologies and expanding indications. The growing pipeline of clinical trials and product innovations is helping manufacturers differentiate offerings in a crowded antispasmodic and antiemetic market.

What Are the Key Drivers of Growth in the Hyoscine Market?

The growth in the hyoscine market is driven by several factors related to drug reformulation, end-user demand, therapeutic versatility, and global health trends. First, the rising incidence of motion sickness and gastrointestinal disorders in both developed and developing countries is increasing the demand for fast-acting, well-tolerated symptomatic treatments. Second, the growing aging population, particularly in North America, Europe, and Japan, is fueling demand for hyoscine-based products in palliative care, Parkinson's disease management, and postoperative symptom relief. Third, the increasing availability of over-the-counter hyoscine products in consumer health markets is expanding its reach beyond prescription-only settings, especially for travel-related applications. Fourth, advancements in drug delivery systems-such as patches, nasal sprays, and extended-release tablets-are boosting patient compliance and therapeutic efficacy, making hyoscine more appealing across multiple demographics. Fifth, pharmaceutical companies are actively investing in regional market expansion, especially in Asia-Pacific and Latin America, where demand for gastrointestinal and CNS-related therapies is rapidly rising. Lastly, strong clinical evidence, ongoing research, and regulatory support are solidifying hyoscine’s position in the global pharmaceutical landscape as a trusted, adaptable, and increasingly innovative therapeutic option.

SCOPE OF STUDY:

The report analyzes the Hyoscine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hyoscine Butyl Bromide Type, Hyoscine Hydrobromide Type); Administration (Oral Administration, Patches Administration, Injections Administration)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Actylis
  • AdvaCare Pharma
  • Alchem International Pvt. Ltd
  • Aspen API
  • Atman Pharmaceuticals
  • Baxter International Inc.
  • Bazayan & Co
  • Biotechnica DWC
  • Caleb Pharmaceuticals Inc.
  • GlaxoSmithKline plc (GSK)
  • Jai Radhe Sales
  • LGM Pharma
  • Linnea SA
  • MYUNGMOON PHARM CO., LTD.
  • Perrigo Company plc
  • Phytex Australia
  • Rumit Group of Companies
  • Sarv Biolabs Pvt. Ltd
  • Transo-Pharm Handels GmbH
  • Zhejiang Ausun Pharmaceutical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hyoscine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Motion Sickness and Gastrointestinal Disorders Throws the Spotlight on Hyoscine
    • Growing Demand for Antispasmodic Therapies Spurs Use of Hyoscine in Digestive and Urinary Applications
    • Expansion of OTC Drug Markets Strengthens the Business Case for Hyoscine-Based Motion Sickness Medications
    • Here's How Increasing Global Travel and Tourism Accelerates Demand for Transdermal and Oral Hyoscine Products
    • Growth in Geriatric Population Expands the Addressable Market for Hyoscine in Neurological and Palliative Care
    • Advancements in Drug Delivery Systems Drive Innovation in Buccal, Patch, and Sublingual Hyoscine Formulations
    • Here's the Story: Non-Invasive Delivery Preferences Fuel Adoption of Transdermal Scopolamine Patches
    • Rising Use in Preoperative and Postoperative Care Supports Market Demand in Hospital and Surgical Settings
    • Increased Clinical Research into CNS Disorders Strengthens Potential Use Cases in Alzheimer's and Parkinson's Symptom Management
    • Growing Demand for Anti-Nausea Medications in Oncology Drives Use of Hyoscine as Adjunct Therapy
    • Global Expansion of Generic Hyoscine Manufacturing Boosts Accessibility and Competitive Pricing
    • Evolving Consumer Preferences for Plant-Derived and Natural Compounds Align with Botanical Origin of Hyoscine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hyoscine Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hyoscine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hyoscine Butyl Bromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hyoscine Butyl Bromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hyoscine Butyl Bromide Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hyoscine Hydrobromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hyoscine Hydrobromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hyoscine Hydrobromide Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patches Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patches Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patches Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injections Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injections Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injections Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • JAPAN
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • CHINA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • EUROPE
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hyoscine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • FRANCE
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • GERMANY
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hyoscine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • INDIA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hyoscine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hyoscine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • AFRICA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030

IV. COMPETITION